コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al anxiety, depression, and/or posttraumatic stress disorder).
2 psychiatric conditions such as posttraumatic stress disorder.
3 are reduced in patients with post-traumatic stress disorder.
4 major depressive disorder and posttraumatic stress disorder.
5 h excessive stress, including post-traumatic stress disorder.
6 dicating a high probability of posttraumatic stress disorder.
7 ms of anxiety, depression, and posttraumatic stress disorder.
8 oms of anxiety, depression, or posttraumatic stress disorder.
9 l memory deficits described in posttraumatic stress disorder.
10 anxiety disorders, including post-traumatic stress disorder.
11 d the development of acute or post-traumatic stress disorder.
12 depression, schizophrenia, or post-traumatic stress disorder.
13 15 item measuring symptoms of posttraumatic stress disorder.
14 such as major depression and post-traumatic stress disorder.
15 major depressive disorder and posttraumatic stress disorder.
16 y dysfunction in, for example, posttraumatic stress disorder.
17 depression, schizophrenia, or post-traumatic stress disorder.
18 uding depression, anxiety and post-traumatic stress disorder.
19 itions, such as depression and posttraumatic stress disorder.
20 n in insomnia, depression, and posttraumatic stress disorder.
21 ad an antemortem diagnosis of post traumatic stress disorder.
22 nal arousal that characterize post-traumatic stress disorder.
23 such as anxiety disorders and posttraumatic stress disorder.
24 is an effective treatment for posttraumatic stress disorder.
25 se SGK1 in the development of post-traumatic stress disorder.
26 ents showed a delayed onset of posttraumatic stress disorder.
27 sorders, including anxiety and posttraumatic stress disorder.
28 s of depression, anxiety, and post-traumatic stress disorder.
29 1.1%) of 470 met criteria for post-traumatic stress disorder.
30 ith anxiety disorders such as post-traumatic stress disorder.
31 tral sensory hyperactivity in post-traumatic stress disorder.
32 al aetiological mechanism for post-traumatic stress disorder.
33 , such as chronic anxiety and post-traumatic stress disorder.
34 essive-compulsive disorder, or posttraumatic stress disorder.
35 ns, with a particular focus on posttraumatic stress disorder.
36 including major depression and posttraumatic stress disorder.
37 ry prevention and treatment of posttraumatic stress disorder.
38 as autism, schizophrenia, and posttraumatic stress disorder.
39 nt possibility for reducing comorbid SUDs in stress disorders.
40 l and functional changes in individuals with stress disorders.
42 ety 1.66 (1.12-2.46), and for post-traumatic stress disorder 1.70 (1.17-2.48) than people who were no
44 (PTSD) was measured with the Post-traumatic Stress Disorder 8 items (PTSD-8) and severe mental illne
45 alized anxiety disorder, 7.9%; posttraumatic stress disorder, 9.8%; alcohol dependence, 11.2%; and no
46 hiatric disorders (depression, posttraumatic stress disorder, addiction, social anxiety disorder, bip
47 that might offset the risk of post-traumatic stress disorder after cardiovascular disease events.
48 ned positive for depression or posttraumatic stress disorder after return from deployment and particu
49 Interestingly, patients with post-traumatic stress disorder also showed heightened frontal processin
50 04 for depression, p=0.01 for post-traumatic stress disorder), although the difference in anxiety sco
52 New possibilities for treating posttraumatic stress disorder and anxiety disorders involving abnormal
53 nt overlap of symptoms between posttraumatic stress disorder and anxiety disorders, the latter has re
54 chanisms for the link between post-traumatic stress disorder and cardiovascular disease, and several
55 ed with placebo on symptoms of posttraumatic stress disorder and depression and health-related qualit
58 ia), mental health status (eg, posttraumatic stress disorder and depression), nonocular pain, and med
67 f other external injuries, blood loss, acute stress disorder and the potential for hypoxic brain inju
68 erstand the neural underpinnings of comorbid stress disorders and drug use by determining whether the
69 There is substantial comorbidity between stress disorders and substance use disorders (SUDs), and
70 ety, obsessive-compulsive, and posttraumatic stress disorders and to evaluate whether antidepressants
72 the apolipoprotein E4 allele, post-traumatic stress disorder, and genetic risk for schizophrenia and
73 neralized anxiety disorder and posttraumatic stress disorder, and past 12-month alcohol dependence an
74 generalized anxiety disorder, posttraumatic stress disorder, and social anxiety disorder, as well as
75 outcomes included history of post-traumatic-stress-disorder, anesthesia type, first or second eye, p
76 disorders (any disorder, mood, posttraumatic stress disorder, anxiety, alcohol use disorders, drug us
77 orted a greater prevalence of post-traumatic stress disorder, anxiety, or depression than did control
79 ted psychopathologies such as post-traumatic stress disorder are characterized by impaired extinction
80 erapeutic effects for treating posttraumatic stress disorder are related to altering emotional memory
81 disabling condition which, along with acute stress disorder (ASD), is categorized as a trauma- and s
83 s of depression, anxiety, and post-traumatic stress disorder between participants displaced by floodi
84 sychiatric disorders, such as post-traumatic stress disorder, bipolar disorder and depression, are al
85 (mean scores >35), followed by posttraumatic stress disorder, borderline personality disorder, and co
86 (depression, anxiety, stress, posttraumatic stress disorder, burden, activity restriction, and healt
87 ve in patients suffering from post-traumatic stress disorder by suppressing activity in the amygdala
88 ) is a highly prevalent late-onset oxidative stress disorder characterized by progressive loss of HCE
89 S-I) and the stressor-specific Posttraumatic Stress Disorder Checklist (PCL-S); secondary measures we
90 umatic stress (measured by the Posttraumatic Stress Disorder Checklist [PCL]), personally identified
92 posttraumatic stress symptoms (Posttraumatic Stress Disorder Checklist for DSM-5), functional impairm
95 x of the studies screened for post-traumatic stress disorder, depression, and anxiety; one study scre
97 act of psychiatric conditions (posttraumatic stress disorder, depression, anxiety, and substance abus
98 obsessive-compulsive disorder, posttraumatic stress disorder, depressive disorders, bipolar disorder,
101 Three percent of the patients had an acute stress disorder diagnosis 4 weeks after transfer to post
102 mild traumatic brain injury or posttraumatic stress disorder display alterations on ASL images in the
103 as well as the prevalence of post-traumatic stress disorder due to cardiovascular disease events and
104 igence was not associated with posttraumatic stress disorder, eating disorders, and anxiety disorders
105 gher risk of comorbidity with post-traumatic stress disorder (eight studies, 2494 participants; 3.60,
106 Secondary outcomes included posttraumatic stress disorder experienced by the family and measured b
107 icture viewing, patients with post-traumatic stress disorder failed to demonstrate alpha adaptation,
109 sychiatric Genomics Consortium-Posttraumatic Stress Disorder group (PGC-PTSD) combined genome-wide ca
111 se states such as depression, post-traumatic stress disorder, hypertension, diabetes, and osteopenia,
112 rs4523957, is associated with posttraumatic stress disorder in humans, consistent with the facilitat
116 increased rates of depression, anxiety, and stress disorders in families of critically ill patients.
122 more obesity, depression, and posttraumatic stress disorder, less obstructive coronary artery diseas
123 ing mental disorders, such as post-traumatic stress disorder, little is known about the source of ind
125 r [GAD]-2 anxiety scale), and post-traumatic stress disorder (measured by the Post-Traumatic Stress D
126 stem, a known risk factor for post-traumatic stress disorder, modulates the stress-induced shift from
127 jects (n = 20), patients with post-traumatic stress disorder (n = 25) demonstrated intrinsic sensory
128 ; major depression, n=38; and post-traumatic stress disorder, n=50), we examine the dimensional relat
130 revealed a lower prevalence of posttraumatic stress disorder (odds ratio, 0.23; 95% CI, 0.07-0.72; p
131 (13.8%) who received placebo (posttraumatic stress disorder: odds ratio, 0.82; 95% CI, 0.55-1.20; p
132 e formation and persistence of posttraumatic stress disorder, of which sleep impairments are a core f
133 een relatively little study of posttraumatic stress disorder or obsessive-compulsive disorder to date
134 (OR, 1.5; 95% CI, 1.06-2.05), posttraumatic stress disorder (OR, 1.6; 95% CI, 1.27-2.10), and antiso
135 priori seeds relevant to TMS, posttraumatic stress disorder, or MDD (subgenual anterior cingulate co
137 stress, caregiver burden, and posttraumatic stress disorder outcomes in informal caregivers of long-
140 IFICANCE STATEMENT Anxiety and posttraumatic stress disorder patients generalize fear to nonfearful f
141 a exposure is known to predict posttraumatic stress disorder (PTSD) after subsequent traumas, it is u
142 uded depression, anxiety, and post-traumatic stress disorder (PTSD) among family 3 and 6 months after
143 stressful experiences, such as posttraumatic stress disorder (PTSD) and depression, are not well unde
146 tionately have higher rates of posttraumatic stress disorder (PTSD) and experience greater symptom se
147 ty is a predominant feature of posttraumatic stress disorder (PTSD) and may reflect disease vulnerabi
150 Part of the symptomatology of post-traumatic stress disorder (PTSD) are alterations in arousal and re
151 KEY POINTS: Patients with post-traumatic stress disorder (PTSD) are at a significantly higher ris
152 compulsive disorder (OCD), and posttraumatic stress disorder (PTSD) are common mental disorders in ch
155 We prospectively examined posttraumatic stress disorder (PTSD) as a long-term consequence of war
156 idate the mechanisms by which post-traumatic stress disorder (PTSD) at a young age contributes to an
158 psychiatric disorders such as posttraumatic stress disorder (PTSD) compared with those characterized
159 nociception, and humans with post-traumatic stress disorder (PTSD) exhibit co-morbid chronic pain an
163 urobiological understanding of posttraumatic stress disorder (PTSD) has been partially attributed to
164 ictability of animal models of posttraumatic stress disorder (PTSD) has required active collaboration
165 antagonist prazosin for combat posttraumatic stress disorder (PTSD) in 67 active duty soldiers, basel
167 ical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of the union, yet
168 ogical mechanisms that predict posttraumatic stress disorder (PTSD) in recent trauma survivors is imp
169 s a risk factor for developing posttraumatic stress disorder (PTSD) in response to trauma, yet the me
170 g the onset and development of posttraumatic stress disorder (PTSD) indicate widespread immune dysreg
191 marker.SIGNIFICANCE STATEMENT Posttraumatic stress disorder (PTSD) is characterized by maladaptive a
198 etween smoking and symptoms of posttraumatic stress disorder (PTSD) on pain intensity, psychological
199 Parkinson's Disease (PD), and Post-Traumatic Stress Disorder (PTSD) patients with insomnia under a yo
200 d psychotherapy treatments for posttraumatic stress disorder (PTSD) provide insufficient benefit for
201 neural substrates of pediatric posttraumatic stress disorder (PTSD) remain incompletely understood, b
202 d associated distress-that is, posttraumatic stress disorder (PTSD) severity-more than to child soldi
203 ctural brain studies of adult post-traumatic stress disorder (PTSD) show reduced gray matter volume (
206 s (PTEs) of mass conflict and post-traumatic stress disorder (PTSD) symptoms to perinatal depression
207 We assessed patients' mood, post-traumatic stress disorder (PTSD) symptoms, and QOL 6 months post-t
208 ations between war exposures, post-traumatic stress disorder (PTSD) symptoms, depression, anxiety, an
212 tential therapeutic target for posttraumatic stress disorder (PTSD), a mental illness characterized b
213 rauma-evoked syndromes such as posttraumatic stress disorder (PTSD), although the exact contribution
214 order (MDD), 50 patients with post-traumatic stress disorder (PTSD), and 122 healthy controls (HCs).
215 ampus atrophy is implicated in posttraumatic stress disorder (PTSD), and may partly reflect stress-in
216 rans, especially veterans with posttraumatic stress disorder (PTSD), and poses a major risk for adver
217 from ICU included the risk of post-traumatic stress disorder (PTSD), anxiety, depression and post-tra
219 is an effective treatment for posttraumatic stress disorder (PTSD), but a comprehensive, emotion-foc
220 campal and amygdala volumes in posttraumatic stress disorder (PTSD), but findings have not always bee
221 is an effective treatment for posttraumatic stress disorder (PTSD), but many patients do not respond
222 e pathophysiology of pediatric posttraumatic stress disorder (PTSD), but the few studies to date have
223 spontaneous brain activity in posttraumatic stress disorder (PTSD), but the findings are inconsisten
224 vity is present in people with posttraumatic stress disorder (PTSD), but the molecular mechanisms of
225 hological conditions including posttraumatic stress disorder (PTSD), characterized by debilitating tr
226 post-deployment screening for post-traumatic stress disorder (PTSD), depression, anxiety, or alcohol
227 rotein, have been described in posttraumatic stress disorder (PTSD), generalized anxiety disorder (GA
228 n evidence-based treatment for posttraumatic stress disorder (PTSD), has not been tested as an indivi
229 s of three disorder categories-posttraumatic stress disorder (PTSD), major depressive disorder (MDD),
230 y prevalence postdeployment of posttraumatic stress disorder (PTSD), major depressive episode, genera
231 of fear, a cardinal feature of posttraumatic stress disorder (PTSD), manifests as inappropriate, unco
232 py, an effective treatment for posttraumatic stress disorder (PTSD), relies on extinction learning pr
233 about 30-50% of patients with posttraumatic stress disorder (PTSD), symptoms persist after treatment
234 diovascular disease (CVD), and posttraumatic stress disorder (PTSD), the sentinel stress-related ment
235 g anxiety disorders, including posttraumatic stress disorder (PTSD), the underlying mechanisms are un
236 ct of traumatic experience on post-traumatic stress disorder (PTSD), this study aims to explore the a
237 sponse to traumatic stress on post-traumatic stress disorder (PTSD), this study examined longitudinal
238 is perturbed in patients with posttraumatic stress disorder (PTSD), with some studies indicating exc
262 is a vulnerability factor for posttraumatic stress disorder (PTSD); however, our understanding is li
263 ration (VA) have a history of post-traumatic-stress-disorder (PTSD), and there exists a higher rate o
264 depression, bipolar disorder, post-traumatic stress disorder [PTSD], substance and alcohol abuse, and
266 a unique sensory pathology of post-traumatic stress disorder (ruling out effects merely reflecting an
268 % CI, 1.02-1.30; P = .02), and posttraumatic stress disorder score (OR, 1.04; 95% CI, 1.01-1.08; P =
269 verall DE symptom severity and posttraumatic stress disorder scores and tear breakup time (DEQ5 model
270 as a treatment for refractory post-traumatic stress disorder, social anxiety in autistic adults, and
271 , bipolar disorder, psychosis, posttraumatic stress disorder, substance dependence, current abuse, in
272 ife events, and depressive and posttraumatic-stress-disorder symptom scores with placental mtDNAcn in
273 lences of clinically important posttraumatic stress disorder symptoms (95% CI) were 25% (18-34%) and
274 hole-brain cortical thickness, posttraumatic stress disorder symptoms (PTSD) and depression symptoms.
275 eneral anxiety, depression, or posttraumatic stress disorder symptoms during 2-year follow-up had sup
277 increased lifetime stress and posttraumatic stress disorder symptoms explained the majority of the e
280 neral anxiety, depression, and posttraumatic stress disorder symptoms ranged from 38% to 44%, 26% to
281 24), and pooled prevalences of posttraumatic stress disorder symptoms were 17% (10-26%) and 34% (22-5
285 eneral anxiety, depression, or posttraumatic stress disorder symptoms, and these symptoms tended to c
289 es, more women presented with post-traumatic stress disorder than did men in two studies, and landmin
290 nd device-based treatments for posttraumatic stress disorder that have been developed via a bench to
291 construct a vicious cycle in post-traumatic stress disorder that is in action even at rest, implicat
293 ta suggests that a history of post-traumatic-stress-disorder was correlated with higher pain scores,
294 cidate a sensory pathology of post-traumatic stress disorder, we examined intrinsic visual cortical a
295 ms of anxiety, depression, and posttraumatic stress disorder were found to be common 1 year after cri
296 Scores for depression and post-traumatic stress disorder were higher in people who were displaced
298 ls of depression, anxiety, and posttraumatic stress disorder, which are strongly associated with self
299 vidence for an association of post-traumatic stress disorder with incident cardiovascular disease ris
300 prehensive assessment of the associations of stress disorders with a variety of outcomes, and we foun
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。